heart problems Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Non-Binary (1)
Any (1)

Phase 3 (1)
Unknown (1)

Interventional (1)

Children's Oncology Group (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadacute myeloid leukemia

I am/have/hadblood count

I am/have/hadblast cells

I am/have/hadheart problems

I am/have/hadcongenital heart block

I am/have/haddown syndrome

I am/have/hadallogeneic hematopoietic stem cell transplant

I am/have/hadblast count

I am/have/hadwilliams syndrome

I am/have/hadblood cell count

I am/have/hadwhite blood cell count

I am/have/hadleukemia

I am/have/hadflt3 gene

I am/have/hadresidual leukemic cells

I am/have/hadmyeloid leukemia

I am/have/hadfibrosis

I am/have/hadneuropsychological testing

I am/have/hadvision test

I am/have/hadleukemic cells

I am/have/hadcell transplantation

added new label for I am/have/had

more

I am looking for

I am looking forgilteritinib

I am looking foranthracyclines

I am looking formethotrexate

I am looking forgemtuzumab

I am looking forcytarabine

I am looking forcytarabine/daunorubicin

I am looking foretoposide

I am looking forgemtuzumab ozogamicin

I am looking formitoxantrone

I am looking forchemotherapy drug

I am looking fordaunorubicin

I am looking foranthracycline

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
all
Hematology
Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

CPX-351 is made up of daunorubicin and cytarabine and is made in a way that makes the drugs stay in the bone marrow longer and could be less likely to cause heart problems than traditional anthracycline drugs, a common class of chemotherapy drug. Some acute myeloid leukemia patients have an …

acute myeloid leukemia

heart problems

allogeneic hematopoietic stem cell transplant

williams syndrome

gilteritinib

0 views
2 annotations
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.